In terms of disease progression, there was no statistical significance in age, sex, smoking history, ECOG-PS, pathological type, brain metastasis, liver metastasis, bone metastasis, lung metastasis, adrenal metastasis, clinical stage, line of treatment, EGFR mutation and PD-L1 TPS. Here, EGFR is linked to bone metastasis.